生物可吸收补片初次食管旁疝修补的长期结局及BMI与复发的关系
该研究回顾性分析了399例腹腔镜初次食管旁疝修补联合Bio-A®补片加强的患者,按术前BMI分组随访。中位随访44.7个月时7.9%再手术,各组无差异;89.4%患者满意度的长期症状结局良好。结论认为该术式安全可行,BMI与再手术需求无关。
要点
- 腹腔镜初次食管旁疝修补联合Bio-A®补片加强安全可行
- 长期随访再手术率为7.9%,不同BMI组间无差异
- 89.4%患者报告良好至优秀的满意度
核心结论
- 腹腔镜初次食管旁疝修补联合onlay Bio-A®补片安全可行,以患者为中心的长期结局优秀,症状性复发率可接受。
- BMI似乎与需要手术再干预无关。
研究设计与样本
- 回顾性队列研究,查询前瞻性维护数据库,纳入2009年5月28日至2013年12月31日期间接受腹腔镜初次食管旁疝修补联合onlay生物可吸收补片(Bio-A® Gore®)的患者。
- 共纳入399例患者,女性261例(65.4%),平均年龄59.6±13.4岁,平均BMI 29.9±5.0 kg/m2。
- 按术前BMI分组:A组BMI<25(53例,13.3%)、B组BMI 25-29.9(166例,41.6%)、C组BMI 30-34.9(115例,28.8%)、D组BMI≥35(65例,16.3%)。
主要发现
- 4例(1.0%)中转开腹;所有患者均行抗反流手术(225例Nissen、170例Toupet、4例Dor)。
- 305例(76.4%)获得平均44.7±22.8个月随访,其中24例(7.9%)再手术,各组再手术数无差异(P=0.64)。
- 217/305例(71.1%)在平均54.0±13.1个月随访时获得长期症状结局,各组间无显著差异;194/217例(89.4%)报告良好至优秀满意度,各组间无显著差异。
临床怎么用
- 对于适合的食管旁疝患者,腹腔镜初次修补时可考虑使用onlay Bio-A®补片加强,长期症状结局和满意度良好。
- 术前BMI高低不应作为拒绝手术的依据,因BMI与再手术需求无关。
局限性
- 回顾性研究设计,存在选择偏倚和信息偏倚可能。
- 单中心经验,补片类型单一,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic repair remains the gold-standard treatment for paraesophageal hernia (PEH). We analyzed long-term symptomatic outcomes and surgical reintervention rates after primary PEH repair with onlay synthetic bioabsorbable mesh (W. L. Gore & Associates, Inc., Flagstaff, AZ) and examined body mass index (BMI) as a possible risk factor for poor outcomes and for recurrence. METHODS: We queried a prospectively maintained database to identify patients who underwent laparoscopic primary PEH repair with onlay patch of a bioprosthetic absorbable mesh (Bio-A® Gore®) between 05/28/2009 and 12/31/2013. Electronic health records were accessed to record demographic and operative data and were reviewed up to the present to identify any repeat procedures. Patients were grouped according to preoperative BMI (A: BMI < 25; B: BMI = 25-29.9; C: BMI = 30-34.9; D: BMI ≥ 35). Patients completed standardized satisfaction and symptom surveys. RESULTS: In total, 399 patients were included. Most patients (n = 261; 65.4%) were women. Mean age was 59.6 ± 13.4 years; mean BMI was 29.9 ± 5.0 kg/m2. The patients were grouped as follows: A, 53 patients (13.3%); B, 166 (41.6%); C, 115 (28.8%); D: 65 (16.3%). Four procedures (1.0%) were converted from laparoscopy to open procedures. All patients underwent an antireflux procedure (225 Nissen, 170 Toupet, 4 Dor). A mean follow-up of 44.7 ± 22.8 months was available for 305 patients (76.4%). 24/305 patients (7.9%) underwent reoperation, and the number of reoperations did not differ among groups (P = 0.64). Long-term symptomatic outcomes were available for 217/305 patients (71.1%) at a mean follow-up of 54.0 ± 13.1 months; no significant difference was observed among groups. 194/217 patients (89.4%) reported good to excellent satisfaction, with no significant differences among the groups. CONCLUSIONS: Laparoscopic primary PEH repair with onlay Bio-A® mesh is a safe and feasible procedure with excellent long-term patient-centered outcomes and acceptable symptomatic recurrence rate. BMI does not appear to be related to the need for surgical reintervention.
引用
- Olson MT, Singhal S, Panchanathan R, et al. Primary paraesophageal hernia repair with Gore® Bio-A® tissue reinforcement: long-term outcomes and association of BMI and recurrence. Surg Endosc. 2018. PMID: 29761272. doi:10.1007/s00464-018-6200-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。